You are here:
Funding
- Overview
- Funding Opportunities
- Funding Process
- Funded Research
- Clinical Research
- Policies & Guidelines
Policies and Guidelines for Investigator-Initiated Clinical Trials
Reviewed March 12, 2012
The NIAMS is committed to improving the health of patients with rheumatic, musculoskeletal, and skin diseases by supporting investigator-initiated clinical trials that lead to better clinical outcomes. The NIAMS' goal is to identify and fund trials that are as timely and informative as possible, and which will lead to improvements in clinical practices for disease prevention, diagnosis, and treatment. To this end, NIAMS has enhanced its clinical trials program.
How to Apply for Funding for Planning and Implementing a Clinical Trial
NIAMS Investigator-Initiated Clinical Trials Policies
- Pilot and Feasibility Clinical Research Grants (R21)
- NIAMS Clinical Trial Planning Grants (U34)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UM1/U01)
Supporting Information
Planning and Implementation Milestones
Consultation
Letters of Request
Tools to Use Once You Find Out You Will Be Funded
Data and Safety Monitoring
Clinical Study Documents
Clinical Trials Registration
NIH and Federal Policies
For More Information
Contact a NIAMS Clinical Coordinator
